首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 向倩
2023
FA
Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study
CLIN TRANSL MED, 10.1002/ctm2.1263
CA
Targeting integrin pathways: mechanisms and advances in therapy
SIGNAL TRANSDUCT TAR, 10.1038/s41392-022-01259-6
2022
FA
Genetic variations in relation to bleeding and pharmacodynamics of dabigatran in Chinese patients with nonvalvular atrial fibrillation: A nationwide multicentre prospective cohort study
CLIN TRANSL MED, 10.1002/ctm2.1104
2021
CA
Does Repeat Revascularization Introduce Bias for Reducing Mortality in the Antiplatelet Therapy Group?
JACC, 10.1016/j.jacc.2021.08.063
2019
FA
The predictive value of circulating microRNAs for venous thromboembolism diagnosis: A systematic review and diagnostic meta-analysis
THROMB RES, 10.1016/j.thromres.2019.07.024
FA
The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations
ASIAN J PHARM SCI, 10.1016/j.ajps.2019.06.002
FA
Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic
PHARMACOL THERAPEUT, 10.1016/j.pharmthera.2019.107393
2018
CA
Candidate gene and pathway analyses identifying genetic variations associated with prasugrel pharmacokinetics and pharmacodynamics
THROMB RES, 10.1016/j.thromres.2018.11.013